43,774 research outputs found

    Predicting variation of DNA shape preferences in protein-DNA interaction in cancer cells with a new biophysical model

    Full text link
    DNA shape readout is an important mechanism of target site recognition by transcription factors, in addition to the sequence readout. Several models of transcription factor-DNA binding which consider DNA shape have been developed in recent years. We present a new biophysical model of protein-DNA interaction by considering the DNA shape features, which is based on a neighbour dinucleotide dependency model BayesPI2. The parameters of the new model are restricted to a subspace spanned by the 2-mer DNA shape features, which allowing a biophysical interpretation of the new parameters as position-dependent preferences towards certain values of the features. Using the new model, we explore the variation of DNA shape preferences in several transcription factors across cancer cell lines and cellular conditions. We find evidence of DNA shape variations at FOXA1 binding sites in MCF7 cells after treatment with steroids. The new model is useful for elucidating finer details of transcription factor-DNA interaction. It may be used to improve the prediction of cancer mutation effects in the future

    Synthetic biology—putting engineering into biology

    Get PDF
    Synthetic biology is interpreted as the engineering-driven building of increasingly complex biological entities for novel applications. Encouraged by progress in the design of artificial gene networks, de novo DNA synthesis and protein engineering, we review the case for this emerging discipline. Key aspects of an engineering approach are purpose-orientation, deep insight into the underlying scientific principles, a hierarchy of abstraction including suitable interfaces between and within the levels of the hierarchy, standardization and the separation of design and fabrication. Synthetic biology investigates possibilities to implement these requirements into the process of engineering biological systems. This is illustrated on the DNA level by the implementation of engineering-inspired artificial operations such as toggle switching, oscillating or production of spatial patterns. On the protein level, the functionally self-contained domain structure of a number of proteins suggests possibilities for essentially Lego-like recombination which can be exploited for reprogramming DNA binding domain specificities or signaling pathways. Alternatively, computational design emerges to rationally reprogram enzyme function. Finally, the increasing facility of de novo DNA synthesis—synthetic biology’s system fabrication process—supplies the possibility to implement novel designs for ever more complex systems. Some of these elements have merged to realize the first tangible synthetic biology applications in the area of manufacturing of pharmaceutical compounds.
    corecore